Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,036.50
(
0.19%
)
US TECH 100
25,594.80
(
0.39%
)
Dow Jones
48,571.38
(
0.22%
)
Brent Oil
94.92
(
2.44%
)
Bitcoin
75,353.34
(
0.70%
)
News Focus
News Focus
Post# of 517341
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

falconer66a

Send PM Follow Ignore
Followers 166
Posts 2895
Boards Moderated 0
Alias Born 01/29/2004

falconer66a

Re: Investor2014 post# 301051

Sunday, 02/28/2021 10:54:22 AM

Sunday, February 28, 2021 10:54:22 AM

Post# of 517341
Or, before.

By prompt, I am assuming you mean after a positive readout from the planned P3 PDD trial perhaps some time in 2023?


Others cogent with the multitude of details regarding the conduct of acceptable drug trials can more accurately project when the FDA approves blarcamesine. No matter, the data in the paper be validating and supportive.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News